Financial/Revenue Cycle Management
European legislation, workforce trends, women’s health, AI implementations, and more will be in the spotlight at HIMSS25 Europe at the Palais des Congrès de Paris, France on 10-12 June 2025.
A new tool can provide healthcare customer service representatives with real-time financial data on patients to guide more empathetic conversations about payment options, says RevSpring President Nicole Rogas.
Dr. Don Rucker, chief strategy officer at 1upHealth, who led ONC in the first Trump administration, says the government is returning to pre-pandemic norms, rather than making cuts to Medicare and Medicaid.
Fostering a culture of transparency, accuracy, and respect for patient data may be key to fully realise AI's potential in healthcare, says a healthcare data analyst.
Hal Andrews, CEO of Trilliant Health, explains the significance of the legislation, requiring every not-for-profit hospital to have charges equal to or less than the state average, which was signed by Governor Mike Braun in May.
Michael Needham, principal at Efficio, says the Trump administration's tariffs create uncertainty and indecision for business.
The organization has a $3.6 million fundraising campaign, with dollar-for-dollar matching, to support the Global Measles and Rubella Laboratory Network in its mission to control both diseases. Anil Soni, CEO of the WHO Foundation, explains.
Anu Sharma, founder and CEO of the tech-enabled Millie, says that because 42% of all births in the U.S. are paid for by Medicaid, which has lower rates than other insurance, women's healthcare delivery operations are threatened.
Small providers struggle for survival, and security risks only exacerbate the challenge. But by sharing technologies and making use of resources like virtual CISOs, some hospitals are staying ahead of their biggest closure risks.
In part two of our new Emerging Technologies Series, Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, highlights the venture capital firm's rigorous evaluation of a technology's potential for maturation.